Lakefront Biotherapeutics (LKFT) Prepaid Assets (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Prepaid Assets for 13 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.

• Quarterly Prepaid Assets fell 86.99% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 86.99% YoY) and the FY2025 annual result came in at $8.0 million, down 77.45% from the prior year.
• Prepaid Assets slipped to $4.6 million in Q1 2026 per LKFT's latest filing, from $8.0 million in the prior quarter.
• Over the last five years, Prepaid Assets for LKFT reached as high as $35.6 million in Q1 2025 and fell as low as $4.6 million in Q1 2026.
• A 5-year average of $21.0 million and a median of $17.9 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2023 — Prepaid Assets jumped 168.16% — and 2026, when it slumped 86.99%.
• Year by year, Prepaid Assets stood at $26.5 million in 2022, then slumped by 35.04% to $17.2 million in 2023, then jumped by 105.08% to $35.3 million in 2024, then slumped by 77.45% to $8.0 million in 2025, then plunged by 41.8% to $4.6 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $4.6 million, $8.0 million, and $12.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.